Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.37 USD | -0.81% |
|
-4.10% | -15.75% |
07-15 | JPMorgan Trims Price Target on Alkermes to $31 From $32, Maintains Neutral Rating | MT |
07-01 | Alkermes plc(NasdaqGS:ALKS) dropped from Russell 2000 Dynamic Index | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.75% | 3.95B | |
+22.15% | 46.56B | |
+45.32% | 41.67B | |
-2.37% | 41.16B | |
+33.84% | 32.4B | |
-6.35% | 28.1B | |
+20.42% | 28.18B | |
+48.83% | 14.52B | |
+45.00% | 13.74B | |
+0.06% | 12.17B |
- Stock Market
- Equities
- ALKS Stock
- News Alkermes plc
- Transcript : Alkermes plc Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-13-2021 07